Emisar | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

231 results for “Emisar”

Trials

View all 130 →

CTRI/2021/05/033408

Diagnose glaucoma with portable perimeter (Elisar AVA)

204 participants

Not yet recruiting

CTRI/2019/05/019122

Compare screening program of Elisar and Humphrey

160 participants

Not yet recruiting

CTRI/2019/05/019127

Diagnose glaucoma with new Elisar mobile perimeter

150 participants

Drugs

View all 18 →

MiCAR-X

luminacins (Eisai)

JNK3 inhibitors (Eisai)

Organizations

View all 23 →

EISAI LIMITED

Ireland

Eisai GmbH

Germany

EISAI INC.

United States

News

View all 60 →

Florida AG sues Eli Lilly, Novo Nordisk, Sanofi and three PBMs over insulin list prices

Eisai Anticipates EU Decision on BioArctic's Lecanemab in Q2

Eisai and Biogen Pursue Subcutaneous Leqembi Approval for Alzheimer's

Page 1 of 24